ArticlePloS one2024
Mortality prediction of inpatients with NSTEMI in a premier hospital in China based on stacking model.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine learning-based prediction of mortality risk from air pollution-induced acute coronary syndrome in the Western Pacific region.Scientific reports · 2026Article
- Comparing Machine Learning Models for Predicting Mortality after Myocardial Infarction: A Systematic Review and Meta-analysis.Archives of academic emergency medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute myocardial infarction (AMI) remains a leading cause of hospitalization and death in China. Accurate mortality prediction of inpatient is crucial for clinical decision-making of non-ST-segment elevation myocardial infarction (NSTEMI) patients.
methodsIn this study, a total of 3061 patients between January 1, 2017 and December 31, 2022 diagnosed with NSTEMI were enrolled in this study. A new method based on Stacking ensemble model is proposed to predict the in-hospital mortality risk of NSTEMI using clinical data. This method mainly consists of three parts. Firstly, oversampling technique was used to alleviate the class imbalance problem. Secondly, the feature selection method of Recursive Feature Elimination (RFE) was selected for effective feature selection. Finally, a unique double-layer stacking model is designed to improve the performance of the algorithm. Seven classical artificial intelligence methods of Logistic Regression (LR), Decision Tree (DT), Support Vector Machine (SVM), Random Forest (RF), Adaptive Boosting (ADB), Extra Tree (ET), and Gradient Boosting Decision Tree (GBDT) were selected as candidate models for the base model of the first layer of the model, and extreme gradient enhancement (XGBOOST) was selected as the meta-model for the second layer.
resultsPatient were divided into the surviving group and the death group, and a total of 57 clinical features showed statistically significant for the two groups and finally included in the subsequent model. The results show that the Area Under Curve (AUC) of the Stacking model proposed in this paper is 0.987, which is higher than that of LR (0.934), DT (0.946), SVM (0.942), RF (0.948), ADB (0.949), ET (0.938) and GBDT (0.920). At the same time, the proposed Stacking model has higher performance than each single model in terms of Accuracy, Precision, Recall and F1 evaluation indicators.
conclusionsThe Stacking model proposed in this paper can integrate the advantages of LR, DT, SVM, RF, ADB, ET and GBDT models to achieve better prediction performance. This model can provide valuable insights for physicians to identify high-risk patients more precisely and timely, thereby maximizing the potential for early clinical interventions to reduce the mortality rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.